Wright Bonilla Quoted on Isolation/Purification Distinction

05 August 2011 FDA Week News

Foley Partner Jacqueline Wright Bonilla was quoted in an article that appeared in FDA Week on August 5, 2011 titled "Gene Patent Ruling’s Isolation v. Purification Distinction Could Impact Biotech." Wright Bonilla discusses a federal court ruling on DNA patent eligibility that distinguishes between the terms isolation and purification. She states that the distinction is not clearly defined with regards to non-nucleic acid biologics and pharma molecules, adding that this distinction might be determined on a product-by-product basis and influence how attorneys draft their patent claims.

Insights